CHRISTINA SCHMIDT: Open Payments
NPI 1609112838 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 18 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $422 · 2025 $436
Food & beverage: $337Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $138 |
| Merck Sharp & Dohme LLC | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| ABBVIE INC. | 1 | $27 |
| TAIHO ONCOLOGY, INC. | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: KEYTRUDA, ALUNBRIG, CALQUENCE, EPKINLY, ENHERTU, MONJUVI, LONSURF, Polivy.
Industry payments across KS — which companies pay providers there.
